Neon Therapeutics (Neon Therapeutics) 3-Year Dividend Growth Rate : 0.00% (As of Mar. 2020)

View and export this data going back to 2018. Start your Free Trial

What is Neon Therapeutics 3-Year Dividend Growth Rate?

Neon Therapeutics's Dividends per Share for the three months ended in Mar. 2020 was $0.00.

The historical rank and industry rank for Neon Therapeutics's 3-Year Dividend Growth Rate or its related term are showing as below:

NTGN's 3-Year Dividend Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 14.15
* Ranked among companies with meaningful 3-Year Dividend Growth Rate only.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Neon Therapeutics's Dividend Payout Ratio for the three months ended in Mar. 2020 was 0.00. As of today, Neon Therapeutics's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Neon Therapeutics's 3-Year Dividend Growth Rate

For the Biotechnology subindustry, Neon Therapeutics's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neon Therapeutics's 3-Year Dividend Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Neon Therapeutics's 3-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Neon Therapeutics's 3-Year Dividend Growth Rate falls into.

Neon Therapeutics 3-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Neon Therapeutics (NAS:NTGN) 3-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Neon Therapeutics's Dividend Payout Ratio for the quarter that ended in Mar. 2020 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2020 )	/	EPS without NRI (Q: Mar. 2020 )
	=	0	/	-0.58
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Neon Therapeutics 3-Year Dividend Growth Rate Related Terms>

Neon Therapeutics (Neon Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neon Therapeutics Inc (NAS:NTGN) » Definitions » 3-Year Dividend Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

40 Erie Street, Suite 110, Cambridge, MA, USA, 02139

Website

https://www.neontherapeutics.com

Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.

Executives

Cary Pfeffer	director	C/O ELEVEN BIOTHERAPEUTICS, 215 FIRST STREET, SUITE 400, CAMBRIDGE MA 02142
Jolie Siegel	officer: VP, General Counsel	C/O NEON THERAPEUTICS, INC., 40 ERIE ST., SUITE 110, CAMBRIDGE MA 02139
Robert Kamen	director	C/O JOUNCE THERAPEUTICS, INC., 1030 MASSACHUSETTS AVENUE, BOSTON MA 02210
Meryl Zausner	director	C/O NEON THERAPEUTICS, INC., 40 ERIE STREET, SUITE 110, CAMBRIDGE MA 02139
Yasir B. Al-wakeel	officer: Chief Financial Officer	MERRIMACK PHARMACEUTICALS, INC., ONE KENDALL SQUARE, SUITE B7201, CAMBRIDGE MA 02139
Eric S Lander	director	415 MAIN STREET, CAMBRIDGE MA 02142
Stephen A Sherwin	director	C/O CELL GENESYS, INC., 500 FORBES BLVD., SOUTH SAN FRANCISCO CA 94080
Robert I Tepper	director, 10 percent owner	201 BROOKLINE AVE, SUITE 1401, BOSTON MA 02215
Robert B Bazemore	director	33 HAYDEN AVE, LEXINGTON MA 02421
Richard Gaynor	officer: President of R&D	C/O NEON THERAPEUTICS, 40 ERIE STREET, SUITE 110, CAMBRIDGE MA 02139
Access Industries, Llc	other: Affiliate of 10% Owner	730 FIFTH AVENUE, NEW YORK NY 10019
Access Industries Management, Llc	other: Affiliate of 10% Owner	730 FIFTH AVENUE, NEW YORK NY 10019
Access Industries Holdings Llc	10 percent owner	C/O ACCESS INDUSTRIES MANAGEMENT, LLC., 730 FIFTH AVENUE, 20TH FLOOR, NEW YORK NY 10019
Clal Biotechnology Industries Ltd.	other: See Remarks	3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR, TEL AVIV L3 67023
Len Blavatnik	other: Affiliate of 10% Owner	C/O ACCESS INDUSTRIES, 730 FIFTH AVENUE, NEW YORK NY 10019